Review of the last advances in the producing of a functional intestine

A new step has been done to grow something therapeutically useful intestine in the long run (see the last article we published HERE). When it comes to growing intestines, the first inch is the hardest -, especially in a Petri dish. Scientists at Cincinnati Children’s...

Ten years since the discovery of iPS cells. The current state of their clinical application

  Rev Clin Esp. 2017 Jan – Feb;217(1):30-34. doi: 10.1016/j.rce.2016.08.003. Epub 2016 Oct 5. Justo Aznar Ph.D. MD Julio Tudela Pharm Ph.D. Institute of Life Science – Bioethics Observatory Catholic University of Valencia – Spain iPS cells current clinical...

Stem cell research. The two sides of the coin

Science facing market The “heads” of stem cell research Stem cells today represent a great hope for the future of regenerative medicine due to their ability to differentiate into cell lines of almost any tissue, making them a promising therapeutic option for many...

The situation of the clinical use of stem cells

In January 2017, an article was published in JAMA (The Promise of Palliative Care – Translating Clinical Trials to Clinical Care) which, in our opinion, summarises the situation of the clinical use of stem cells extremely well. It begins by referring to the possible sources...

Serotonin produced from neurons obtained with iPS and embryonic stem cells

Serotonin is implicated in functions as important as humour, sadness, feelings of aggression, anxiety and sleep disturbances, among others. A deficiency in serotonin release has been related with schizophrenia, depression, bipolar disorder, obsessive-compulsive disorders, chronic...

Patient’s own menstrual blood stem cells used to treat Asherman’s syndrome

Infertility treatment.”The best option for endometrial regeneration in patients with Asherman’s syndrome.” Asherman’s syndrome is an acquired uterine abnormality characterised by the presence of intrauterine adhesions, and which clinically causes...

First cell gene therapy to treat “Bubble boy” disease has been legalised in Europe

Last July, an article was published in medical journal Blood, which described the success of a cell gene therapy modality to treat the immunodeficiency caused by adenosine deaminase deficiency – “Bubble boy” disease. This is a disease that alters purine...

Retinal tissue produced from iPS cells in animals

One of the possible applications of iPS cells is in the treatment of retinal diseases. Now, a group of researchers from the Riken Institute in Kobe (Japan) see HERE has presented some interesting experiments in which they were able to produce retinal tissue from iPS cells (iPS...

Cerebral organoids produced from embryonic stem cells

A group of researchers in La Jolla, California, have produced three-dimensional  cerebral organoids (“mini-brains”) from human embryonic stem cells, later comparing the functionality of the tissue produced with samples of brain tissue from human foetuses with the same...

Public funds authorised for production of human-animal chimeras

In September 2005, the dedication of public financial aid by the National Health Institutes for experiments on transferring human stem cells to animal embryos to produce chimeras was banned. However, on 4 August this year, this ban was lifted for certain experiments, and it was...
12